Latest ZTS news

Zoetis (ZTS) Stock Drops Despite Market Gains: Important Facts to Note

Zacks Investment Research · Fri, 18 Sep 2026 19:15:50 -0400

Zoetis (ZTS) closed at $71.4 in the latest trading session, marking a -2.22% move from the prior day.

Zoetis: The Worst May Be Priced In

Seeking Alpha · Fri, 18 Sep 2026 10:14:37 -0400

Zoetis faces ongoing headwinds but is now considered a cautious 'Buy' as valuation reflects low-to-mid single-digit growth potential. Q2 results disappointed, with flat revenues and declining U.S. sales, but international and livestock segments showed resilience and growth. Management revised 2026 guidance downward, but ZTS's low valuation multiples and aggressive share buybacks support its fair value case.

Zoetis Stands by Guidance as Pet-Care Weakness and Competition Pressure Sales

MarketBeat · Fri, 18 Sep 2026 01:02:15 -0400

Zoetis NYSE: ZTS executives said the company remains confident in its previously issued guidance despite pressure in the U.S. companion-animal market, citing a weaker pet-care environment and intensified competition in dermatology and parasiticides.

Zoetis: An Undervalued Compounder Hiding In Plain Sight

Seeking Alpha · Thu, 17 Sep 2026 05:52:42 -0400

Zoetis is rated a buy, as I see current headwinds as temporary and the stock undervalued based on my DCF valuation. ZTS faces near-term pressure from weaker U.S. companion animal demand, increased competition, and margin compression due to promotions and rebates. Long-term growth is supported by structural pet humanization trends, international expansion, a robust R&D pipeline, and a growing diagnostics segment.

Zoetis Inc. (ZTS) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Seeking Alpha · Mon, 14 Sep 2026 17:01:37 -0400

Zoetis Inc. (ZTS) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Top 50 High-Quality Dividend Growth Stocks For September 2026

Seeking Alpha · Sun, 13 Sep 2026 23:54:39 -0400

I track a universe of 50 high-quality dividend growth stocks to identify opportune entry points based on valuation and future return potential. Recent upgrades include Eli Lilly, Watsco, and Nike, driven by improved valuations and stronger EPS growth projections. 43 out of 50 stocks currently offer a forward return estimate of at least 10%, with 29 appearing potentially undervalued based on free cash flow mean reversion.

‘Big Short' Michael Burry just updated his portfolio for September

Finbold · Wed, 09 Sep 2026 06:08:57 -0400

Michael Burry, a hedge fund manager and investor known for predicting the 2008 financial crash, has just updated his portfolio, with some notable new positions catching the market's attention.

Market information is provided for research and visualization and is not investment advice.